Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Maurizio Benucci,1 Gianantonio Saviola,2 Mariangela Manfredi,3 Piercarlo Sarzi-Puttini,4 Fabiola Atzeni41Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Florence, Italy; 2Rheumatology and Rehabilitation Unit, Salvatore Maugeri Foundati...
Enregistré dans:
Auteurs principaux: | Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ad8fe6c0e9104037889e1751485fb32b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
par: Benucci M, et autres
Publié: (2018) -
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
par: Benucci M, et autres
Publié: (2016) -
Rituximab therapy in Greek patients with rheumatoid arthritis
par: Haralampos M Moutsopoulos, et autres
Publié: (2008) -
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
par: Joseph M Tuscano, et autres
Publié: (2009) -
Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)